This disclosure is a regulatory intimation pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding an upcoming Board of Directors meeting.
The Board meeting of Arcl Organics Limited is scheduled to be held on Thursday, 12th November 2026. The agenda items for consideration and approval include:
- The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September 2026
- Limited Review Report on Standalone and Consolidated Financial Results for the quarter and half year ended on 30th September 2026
- The declaration of 1st Interim Dividend, if any, for the Financial Year 2026-27
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in shares of the Company has been closed with effect from 1st October 2026. The Trading Window will reopen on 14th November 2026, after the expiry of 48 hours from the submission of the Financial Results to the Stock Exchanges on 12th November 2026.
The disclosure was signed by Deepak Daga, Company Secretary and Compliance Officer (Membership No: A50346) on 4th November 2026 at 18:36:30.